Genetics plays a crucial role in the NB tumorigenesis; in fact, two key factors to identify the progression and prognosis of the tumor are the detection of structural Copy Number Variations (CNVs) and the amplification of the MYCN gene, able to identify those tumors with poor prognosis and rapid progression, independently of age and clinical stage [7,8,9]. Here, MYCN is linked to neuroblastoma.